Soligenix announces presentations at prominent scientific conferences

Princeton, n.j., april 13, 2021 /prnewswire/ -- soligenix, inc. (nasdaq: sngx) (soligenix or the company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today planned conference presentations scheduled through april and may.
SNGX Ratings Summary
SNGX Quant Ranking